Total (n = 3992) | Men (n = 1308) | Women (n = 2684) | P-value | ||
---|---|---|---|---|---|
HVA (degrees) | All | 16.8 ± 7.6 | 14.4 ± 6.2 | 18.0 ± 7.9 | < 0.0001 |
Age < 39 | 15.3 ± 5.0 | 13.6 ± 4.7 | 16.7 ± 4.8 | 0.0004 | |
Age 40–49 | 16.4 ± 6.1 | 14.1 ± 5.3 | 17.9 ± 6.2 | < 0.0001 | |
Age 50–59 | 16.5 ± 6.6 | 13.7 ± 5.0 | 17.6 ± 6.8 | < 0.0001 | |
Age 60–69 | 17.0 ± 7.5 | 14.7 ± 5.9 | 18.2 ± 7.9 | < 0.0001 | |
Age 70–79 | 17.1 ± 8.4 | 14.6 ± 7.0 | 18.1 ± 8.7 | < 0.0001 | |
Age 80≦ | 16.6 ± 8.7 | 14.4 ± 7.2 | 17.9 ± 9.2 | < 0.0001 | |
IPA (degrees) | All | 15.4 ± 5.6 | 16.6 ± 4.8 | 14.9 ± 5.8 | < 0.0001 |
Age < 39 | 17.3 ± 4.2 | 18.0 ± 3.8 | 16.7 ± 4.4 | 0.0501 | |
Age 40–49 | 16.6 ± 4.5 | 16.4 ± 4.6 | 16.7 ± 4.5 | 0.6864 | |
Age 50–59 | 16.3 ± 4.7 | 17.1 ± 4.5 | 16.0 ± 4.8 | 0.0016 | |
Age 60–69 | 15.0 ± 5.5 | 16.5 ± 4.9 | 14.3 ± 5.7 | < 0.0001 | |
Age 70–79 | 14.9 ± 6.1 | 16.4 ± 4.9 | 14.2 ± 6.4 | < 0.0001 | |
Age 80≦ | 15.0 ± 6.2 | 16.1 ± 5.2 | 14.3 ± 6.7 | 0.0007 | |
IMA (degrees) | All | 8.6 ± 2.6 | 8.0 ± 2.5 | 8.9 ± 2.7 | < 0.0001 |
Age < 39 | 7.6 ± 1.7 | 7.4 ± 1.8 | 7.8 ± 1.6 | 0.1787 | |
Age 40–49 | 8.2 ± 2.1 | 7.9 ± 2.0 | 8.4 ± 2.1 | 0.0175 | |
Age 50–59 | 8.1 ± 2.3 | 7.6 ± 2.1 | 8.3 ± 2.3 | 0.0002 | |
Age 60–69 | 8.6 ± 2.6 | 7.9 ± 2.3 | 8.9 ± 2.7 | < 0.0001 | |
Age 70–79 | 9.1 ± 2.9 | 8.3 ± 2.8 | 9.5 ± 2.9 | < 0.0001 | |
Age 80≦ | 9.1 ± 2.9 | 8.8 ± 2.9 | 9.2 ± 2.8 | 0.1432 | |
Contribution of IPA to TVDH (%) | 48.9 ± 17.6 | 54.5 ± 14.6 | 46.2 ± 18.3 | < 0.0001 | |
HV grade (feet [%]) | Normal | 2803 (70.2%) | 1092 (83.5%)a | 1711 (63.8%) | <  0.0001 |
Mild | 928 (23.2%) | 188 (14.4%) | 740 (27.6%)a | ||
Moderate | 222 (5.6%) | 22 (1.7%) | 200 (7.5%)a | ||
Severe | 39 (1.0%) | 6 (0.5%) | 33 (1.2%)a | ||
Prevalence of radiographic HV (feet [%]) | 1189 (29.8%) | 216 (16.5%) | 973 (36.3%) | <  0.0001 | |
Prevalence of HV self-recognition (feet [%]) | 657 (16.5%) | 71 (5.4%) | 586 (21.8%) | <  0.0001 |